-+ 0.00%
-+ 0.00%
-+ 0.00%

TEVA PHARMACEUTICALS SUBMITS NEW DRUG APPLICATION TO FDA FOR OLANZAPINE EXTENDED-RELEASE INJECTABLE SUSPENSION (TEV-'749) FOR THE ONCE-MONTHLY TREATMENT OF SCHIZOPHRENIA IN ADULTS

路透·12/09/2025 13:00:03

登錄查看新聞詳情